 Connection
Mark Steele to Lung Transplantation
This is a "connection" page, showing publications Mark Steele has written about Lung Transplantation.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.954 |
|
|
|
-
Sathy SJ, Martinu T, Youens K, Lawrence CM, Howell DN, Palmer SM, Steele MP. Symptomatic pulmonary allograft Kaposi's sarcoma in two lung transplant recipients. Am J Transplant. 2008 Sep; 8(9):1951-6.
Score: 0.277
-
Reams BD, Musselwhite LW, Zaas DW, Steele MP, Garantziotis S, Eu PC, Snyder LD, Curl J, Lin SS, Davis RD, Palmer SM. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation. Am J Transplant. 2007 Dec; 7(12):2802-8.
Score: 0.065
-
Hadjiliadis D, Steele MP, Chaparro C, Singer LG, Waddell TK, Hutcheon MA, Davis RD, Tullis DE, Palmer SM, Keshavjee S. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant. 2007 Aug; 26(8):834-8.
Score: 0.064
-
Martinu T, Howell DN, Davis RD, Steele MP, Palmer SM. Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients. Chest. 2006 Apr; 129(4):1016-23.
Score: 0.058
-
Palmer SM, Davis RD, Simsir SA, Lin SS, Hartwig M, Reidy MF, Steele MP, Eu PC, Blumenthal JA, Babyak MA. Successful bilateral lung transplant outcomes in recipients 61 years of age and older. Transplantation. 2006 Mar 27; 81(6):862-5.
Score: 0.058
-
Hadjiliadis D, Chaparro C, Gutierrez C, Steele MP, Singer LG, Davis RD, Waddell TK, Hutcheon MA, Palmer SM, Keshavjee S. Impact of lung transplant operation on bronchiolitis obliterans syndrome in patients with chronic obstructive pulmonary disease. Am J Transplant. 2006 Jan; 6(1):183-9.
Score: 0.057
-
Hadjiliadis D, Chaparro C, Reinsmoen NL, Gutierrez C, Singer LG, Steele MP, Waddell TK, Davis RD, Hutcheon MA, Palmer SM, Keshavjee S. Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. J Heart Lung Transplant. 2005 Jul; 24(7 Suppl):S249-54.
Score: 0.056
-
Palmer SM, Grinnan DC, Diane Reams B, Steele MP, Messier RH, Duane Davis R. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir. Clin Transplant. 2004 Apr; 18(2):179-85.
Score: 0.051
-
Lodge BA, Ashley ED, Steele MP, Perfect JR. Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole. J Clin Microbiol. 2004 Mar; 42(3):1376-8.
Score: 0.051
-
Hadjiliadis D, Steele MP, Govert JA, Davis RD, Palmer SM. Outcome of lung transplant patients admitted to the medical ICU. Chest. 2004 Mar; 125(3):1040-5.
Score: 0.051
-
Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. Chest. 2003 Oct; 124(4):1242-9.
Score: 0.049
-
Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, Palmer SM. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant. 2003 Aug; 17(4):363-8.
Score: 0.049
-
Davis RD, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, Palmer SM. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg. 2003 Mar; 125(3):533-42.
Score: 0.047
-
Meltzer EB, Barry WT, D'Amico TA, Davis RD, Lin SS, Onaitis MW, Morrison LD, Sporn TA, Steele MP, Noble PW. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. BMC Med Genomics. 2011 Oct 05; 4:70.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|